Gut Microbiome and Its Associations With Acute and Chronic Gastrointestinal Toxicities in Cancer Patients With Pelvic Radiation Therapy: A Systematic Review

Abstract

AimPelvic radiation therapy (RT) can impact the gut microbiome in patients with cancer and result in gastrointestinal (GI) toxicities. The purpose of this systematic review was to describe the effects of RT on the gut microbiome and the associations between the gut microbiome and GI toxicities in patients treated with pelvic RT.MethodsPubMed, Embase, and Web of Science databases were searched from their earliest records to August 2020. The articles screening process adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The Mixed Method Assessment Tool was used to assess the methodological quality for each included study. All study findings were synthesized and presented in narrative format. Thirteen studies were included. The gut microbiome of fecal samples was analyzed using 16S rRNA sequencing approaches.ResultsThere were disparities in alpha and beta diversities that existed across the studies. Divergent results were found among various phyla, including Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, Cyanobacteria, Fusobacteria, and Deinococcus-Thermus. Moreover, alteration in the gut microbiome diversity and abundance related to cancer treatment was associated with pelvic toxicities, specifically diarrhea. Following treatment, increases in the abundance of Bacteroides was associated with diarrhea and radiation enteritis.ConclusionsPelvic RT can disrupt the diversity and abundance of commensal gut microorganisms. A dysbiotic gut microbiome showed a promising association with radiation enteritis through alterations of the intestinal barrier function, innate immunity, and intestinal repair mechanisms; however, confounders, such as diet, were not thoroughly addressed.

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications

“…RT not only kills cancer cell, but also causes varying degrees of adverse effects on normal tissues and disrupts the diversity and abundance of commensal gut microorganisms. 340 , 356 The RT-induced dysbiotic gut microbiome in turn exacerbates the gastrointestinal toxicity of radiotherapy. 340 Conversely, certain probiotics or probiotic preparations, such as L. rhamnosus and VSL#3 (a probiotic preparation composed of Bifidobacterium species, Lactobacillus , and Streptococcus ) could protect the intestinal epithelium from injury and reduce the side effects of RT.…”

Gut microbiota-derived metabolites and their importance in neurological disorders

“…The inhabitant bacteria in the GIT carry out an assortment of activities that benefit the host, including the digestion of vitamins, and metabolites (bile acids, amino acids, lipids), regulating pH change and peptide production, and influencing cell signalling pathways. Some of these metabolites are commonly altered due to environmental factors and have further been correlated with neurodegenerative symptoms [ 3 ].…”

Skin Microbiome and Treatment-Related Skin Toxicities in Patients With Cancer: A Mini-Review

“…Recent research has been conducted to understand the relationship of the human gut microbiome (7)(8)(9) and vaginal microbiome (10)(11)(12) with human health and disease, including its importance as a biomarker of cancer diagnosis, treatment toxicities, and prognosis (1). However, less is known about the relationship of the skin microbiome with disease, such as cancer and cancer treatment-related toxicities.…”